candidate
Sanofi Acquires Dynavax for $2.2 Billion, Bolstering Adult Vaccine Portfolio
The significant Sanofi Dynavax Acquisition marks a pivotal moment for both pharmaceutical entities, with Sanofi announcing its intent to acquire Dynavax Technologies for approximately $2.2 billion in an all-cash transaction […]